These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4915113)

  • 1. [Use of milk colibacterin to reduce intestinal dysbacteriosis in children].
    Krivogorskiĭ EB; Malkina RD; Mikitina RV
    Pediatriia; 1970 May; 49(5):58-61. PubMed ID: 4915113
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphological changes during intestinal dysbacteriosis in rats].
    Panchishina MV; Rudnitskaia AIu; Shegedin IuI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):110-2. PubMed ID: 1098333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colibacterin in intestinal diseases associated with dysbacteriosis].
    Pospelova VV; D'iakova EI; Vil'shanskaia FL
    Klin Med (Mosk); 1970 May; 48(5):59-61. PubMed ID: 4915001
    [No Abstract]   [Full Text] [Related]  

  • 4. [Application of colibacterin to prevent intestinal diseases in nurseries].
    Borodinova AA
    Vopr Okhr Materin Det; 1970 Mar; 15(3):90-1. PubMed ID: 4910769
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of colibacterin in children with dysentery and in some other intestinal infections].
    Riabinskaia TF; Kanshina OA; D'iakova EI; Koroleva AI
    Vopr Okhr Materin Det; 1967 Jun; 12(7):89-90. PubMed ID: 4887098
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adequate therapy of intestinal dysbacteriosis in children].
    Bel'mer SV; Gasilina TV
    Klin Med (Mosk); 1998; 76(10):35-8. PubMed ID: 9865015
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the microflora of the intestinal contents in children with chronic biliary tract diseases].
    Archakova EV; Tikhaia RI; Zaslavskaia ES; Biliuga TG
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Mar; 51(3):106-9. PubMed ID: 4598048
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dysbacteriosis of the intestine in persons exposed to tetracycline under conditions of production and their treatment with colibacterin].
    Vil'shanskaia FL; Shteĭnberg GB; Kats IZ; Pospelova VV; Krylova NF
    Antibiotiki; 1969 Nov; 14(11):1043-6. PubMed ID: 4907800
    [No Abstract]   [Full Text] [Related]  

  • 9. Selection of a biologically active mutant of Propionibacterium shermanii and the possibility of its use in complex therapy of enteral dysbacteriosis.
    Sidorchuk II; Bondarenko VM
    J Hyg Epidemiol Microbiol Immunol; 1984; 28(3):331-8. PubMed ID: 6548487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of intestinal dysbiosis with Hylakombun].
    Cohrs GW
    Munch Med Wochenschr; 1972 Feb; 114(5):196-200. PubMed ID: 4622014
    [No Abstract]   [Full Text] [Related]  

  • 11. [Colibacterin therapy of children with persistent diarrhea in children's collectives].
    Iakimenko TM; Timaner RS; Kozir LS; Nikulina IM; Kagaeva MM; Stoliar EL; Dubovik LA
    Pediatr Akus Ginekol; 1966; 3():16-9. PubMed ID: 4866216
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunomodulating action of eubiotics].
    Lopatina TK; Bliakher MS; Nikolaenko VN; Nilovskií MN; Pozhalostina LV; Rubtsov OV; Rokosueva LA; Petrova NV
    Vestn Ross Akad Med Nauk; 1997; (3):30-4. PubMed ID: 9181853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of lactic colibacterin for prevention of Sonne dysentery].
    Shulichenko AI; Belaia OS; Sheveleva EB; Edel'shteĭn RI; Kalmykov KZ
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Sep; 49(9):98-101. PubMed ID: 4569267
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of various diseases complicated by dysbacteriosis of the intestines].
    Krasnogolovets VN
    Klin Med (Mosk); 1970 May; 48(5):54-9. PubMed ID: 4915000
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of dysbacteriosis of the intestine and other organs in persons coming into contact with antibiotics (streptomycin, tetracycline and penicillin) under industrial conditions].
    Vil'shanskaia FL; Shteĭnberg GB
    Gig Tr Prof Zabol; 1970 May; 14(5):25-8. PubMed ID: 4915281
    [No Abstract]   [Full Text] [Related]  

  • 16. [The efficacy of intestinal dysbacteriosis correction in patients with bronchial asthma].
    Polosukhina VA; Uzhegova EB; Babadzhanova SS
    Ter Arkh; 1989; 61(3):110-3. PubMed ID: 2741096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dysbacteriosis: topical medical problem].
    Vorobév AA; Abramov NA; Bondarenko VM; Shenderov BA
    Vestn Ross Akad Med Nauk; 1997; (3):4-7. PubMed ID: 9181855
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of bifidumbacterin for the correction of intestinal dysbacteriosis].
    Liz'ko NN; Goncharova GI
    Kosm Biol Aviakosm Med; 1987; 21(4):70-2. PubMed ID: 3657069
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of R factors in children. 3. E. coli strains with transferable resistance to antibiotics in children of various age groups from different environments.
    Seckárová A; Lipková V; Janousková J; Krcméry V
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(2):197-201. PubMed ID: 4606659
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of colibacterin in the treatment of patients with dysentery and its role in restoration of biocenosis].
    Bogomolov BP; Genina GS
    Ter Arkh; 1979; 51(3):94-8. PubMed ID: 375453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.